ENTERAL NUTRITION MARKET ANALYSIS

Enteral Nutrition Market, By Product Type (Standard Enteral Nutrition and Enteral Nutrition for Chronic Illness), By Nutrition Type (Proteins, Carbohydrates, Multi-vitamins and Antioxidants, Amino Acid, Fibers, Minerals, and Others), By Formulation (Powder and Liquid), By Patient Type (Adult, Pediatrics, and Geriatrics), By Application (Cancer, Gastrointestinal Diseases, Diabetes, Critical Care, and Others (Nutrition Deficiency, etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), By End User (Hospitals, Home Care Settings, Retirement Homes, Others (Nursing Care Centers, Rehabilitation Care Centers, etc.)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

In May 2023, Otsuka Pharmaceutical Co., Ltd., a Japan-based pharmaceutical company, announced that it had launched ENORAS Liquid for enteral use, 200 kcal/125 mL, in two flavor coffee and tea flavor. The product is a concentrated (1.6 kcal/mL) polymeric enteric nutrition formula based on the latest nutritional information to efficiently provide nutrients and energy in a small amount.
In May 2022, Abbott, a U.S.-based multinational healthcare company, announced the limited release of its EleCare branded specialty formulas, which have been developed for children and infants suffering from GI disorders or severe food allergies. The released products included EleCare Jr for ages one year and above; and EleCare for infants below 1 year of age.
In April 2022, Meiji Co., Ltd., a Japan-based medical food manufacturing company, announced the launch of the baby formulas Meiji Hohoemi Infant Formula 800g, a powder milk product formula for infants to support the growth of the baby, in Japan